aarnal80 commited on
Commit
cba03c4
·
verified ·
1 Parent(s): 927c763

Rename proa/ginecologia.html to proa/guias/ginecologia.html

Browse files
Files changed (2) hide show
  1. proa/ginecologia.html +0 -140
  2. proa/guias/ginecologia.html +180 -0
proa/ginecologia.html DELETED
@@ -1,140 +0,0 @@
1
- <!DOCTYPE html>
2
- <html lang="es">
3
- <head>
4
- <meta charset="UTF-8">
5
- <meta name="viewport" content="width=device-width, initial-scale=1.0">
6
- <title>Guía PROA - Infecciones Ginecológicas</title>
7
- <script src="https://cdn.tailwindcss.com"></script>
8
- <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
9
- <style>
10
- @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');
11
- body { font-family: 'Montserrat', sans-serif; background-color: #f8fafc; }
12
- .treatment-card { transition: all .3s ease; }
13
- .treatment-card:hover { transform: translateY(-2px); box-shadow: 0 10px 15px -3px rgba(0,0,0,0.1),0 4px 6px -2px rgba(0,0,0,0.05); }
14
- .custom-select { background-image: url("data:image/svg+xml,%3csvg xmlns='http://www.w3.org/2000/svg' fill='none' viewBox='0 0 20 20'%3e%3cpath stroke='%236b7280' stroke-linecap='round' stroke-linejoin='round' stroke-width='1.5' d='M6 8l4 4 4-4'/%3e%3c/svg%3e"); background-position: right .5rem center; background-repeat: no-repeat; background-size: 1.5em 1.5em; }
15
- .treatment-option { background:white; border-left:4px solid #8b5cf6; border-radius:.5rem; padding:1rem; margin:1rem 0 .5rem; }
16
- .treatment-title { font-weight:600; color:#5b21b6; margin-bottom:.5rem; display:flex; align-items:center; gap:.5rem; }
17
- .note-box { background:#f3e8ff; border-left:4px solid #a78bfa; padding:.75rem; margin:1rem 0; border-radius:0 .5rem .5rem 0; }
18
- .note-title { font-weight:600; color:#5b21b6; display:flex; align-items:center; gap:.5rem; margin-bottom:.5rem; }
19
- ul { margin-left:1.25rem; } li { margin-bottom:.25rem; }
20
- optgroup { font-style:italic; }
21
- </style>
22
- </head>
23
- <body class="min-h-screen bg-gray-50">
24
- <div class="max-w-4xl mx-auto px-4 py-8">
25
- <div class="flex items-center gap-3 mb-6">
26
- <div class="bg-purple-600 p-2 rounded-lg text-white"><i class="fas fa-female text-2xl"></i></div>
27
- <h1 class="text-3xl font-bold text-gray-800">Guía PROA - Infecciones Ginecológicas</h1>
28
- </div>
29
- <div class="bg-white rounded-xl shadow p-6 mb-6">
30
- <label for="sel" class="block text-lg font-medium text-gray-700 mb-2 flex items-center gap-2"><i class="fas fa-layer-group text-purple-500"></i> Seleccione categoría</label>
31
- <select id="sel" class="custom-select block w-full pl-3 pr-10 py-2 border border-gray-300 rounded-md focus:ring-purple-500 focus:border-purple-500">
32
- <option value="">-- Elige categoría --</option>
33
- <optgroup label="Cervicitis">
34
- <option value="cerv_sin">Sin etiología conocida</option>
35
- <option value="cerv_gono">N. gonorrhoeae</option>
36
- <option value="cerv_chlam">C. trachomatis</option>
37
- </optgroup>
38
- <optgroup label="Vulvovaginitis">
39
- <option value="vulvo_candi">Candidiasis</option>
40
- <option value="vulvo_vagino">Vaginosis bacteriana</option>
41
- </optgroup>
42
- <optgroup label="Úlceras genitales">
43
- <option value="ulc_sif_pri">Sífilis <1 año</option>
44
- <option value="ulc_sif_lat">Sífilis >1 año</option>
45
- <option value="ulc_neuro">Neurosífilis</option>
46
- </optgroup>
47
- <option value="epi">Enfermedad Inflamatoria Pélvica</option>
48
- <option value="verru">Verrugas genitales</option>
49
- <option value="endo_sec">Endometritis secundaria</option>
50
- </select>
51
- </div>
52
- <div id="result" class="space-y-6"></div>
53
- <div id="store" class="hidden">
54
- <!-- Cervicitis sin etiología conocida -->
55
- <div id="cerv_sin" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
56
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Cervicitis (sin etiología conocida)</h2>
57
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Ceftriaxona 500 mg IM + Azitromicina 1 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
58
- <div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Cefixima 400 mg VO + Azitromicina 2 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
59
- <div class="treatment-option"><div class="treatment-title">Alergia</div><p>Azitromicina 2 g VO + Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
60
- <div class="note-box"><div class="note-title">Observaciones</div><ul><li>Alta sospecha gonococo: Azitromicina preferente.</li></ul></div>
61
- </div>
62
- <!-- Cervicitis gonocócica -->
63
- <div id="cerv_gono" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
64
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Cervicitis por N. gonorrhoeae</h2>
65
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Ceftriaxona 500 mg IM + Azitromicina 1 g VO.</p></div>
66
- <div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Cefixima 400 mg VO + Azitromicina 2 g VO.</p></div>
67
- <div class="treatment-option"><div class="treatment-title">Alergia</div><p>Azitromicina 2 g VO + Gentamicina 240 mg IV o Ciprofloxacino 500 mg VO.</p></div>
68
- <div class="note-box"><div class="note-title">Observaciones</div><ul><li>Gonorrea puede diseminarse (conjuntivitis, artropatía).</li><li>Resistencia a quinolonas ≥50%.</li></ul></div>
69
- </div>
70
- <!-- Cervicitis por Chlamydia -->
71
- <div id="cerv_chlam" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
72
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Cervicitis por C. trachomatis</h2>
73
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Azitromicina 1 g VO dosis única o Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
74
- <div class="note-box"><div class="note-title">Linfogranuloma venéreo</div><p>Doxiciclina 100 mg/12 h VO ×21 d o Azitromicina 1 g VO semanal ×3 semanas.</p></div>
75
- </div>
76
- <!-- Vulvovaginitis candidiasis -->
77
- <div id="vulvo_candi" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
78
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Candidiasis Vulvovaginal</h2>
79
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Clotrimazol 500 mg óvulo único o 200 mg/24 h ×3 d; crema 1% ×7-14 d.</p></div>
80
- <div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Fluconazol 15 mg VO dosis única.</p></div>
81
- <div class="note-box"><div class="note-title">Recurrente / Embarazo</div><ul><li>Recurrente: Fluconazol 150 mg ×3, luego 150 mg semanal ×6 m.</li><li>Embarazadas: Clotrimazol 100 mg ×7 d.</li></ul></div>
82
- </div>
83
- <!-- Vulvovaginitis vaginosis -->
84
- <div id="vulvo_vagino" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
85
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Vaginosis Bacteriana</h2>
86
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Metronidazol 500 mg VO/12 h ×7 d o gel 0.75% 5 g/24 h ×5 d.</p></div>
87
- <div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Clindamicina crema 2% 5 g/24 h ×7 d.</p></div>
88
- <div class="note-box"><div class="note-title">Observaciones</div><ul><li>No ITS, asociado mayor riesgo de ITS.</li></ul></div>
89
- </div>
90
- <!-- Úlceras genitales sífilis primaria -->
91
- <div id="ulc_sif_pri" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
92
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Sífilis primaria/latente precoz</h2>
93
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Penicilina G benzatina 2.4 MUI IM dosis única.</p></div>
94
- <div class="treatment-option"><div class="treatment-title">Alergia</div><p>Azitromicina 2 g VO o Doxiciclina 100 mg/12 h ×14 d.</p></div>
95
- <div class="note-box"><div class="note-title">Embarazo</div><p>Eritromicina 500 mg/6 h ×14 d + Azitromicina 2 g.</p></div>
96
- </div>
97
- <!-- Úlceras sífilis latente tardía -->
98
- <div id="ulc_sif_lat" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
99
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Sífilis latente tardía</h2>
100
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Penicilina G benzatina 2.4 MUI IM semanales ×3 semanas.</p></div>
101
- <div class="treatment-option"><div class="treatment-title">Alergia</div><p>Doxiciclina 100 mg/12 h VO ×28 d.</p></div>
102
- </div>
103
- <!-- Neurosífilis -->
104
- <div id="ulc_neuro" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
105
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Neurosífilis</h2>
106
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Penicilina G IV 3-4 MUI/4 h o 18-24 MUI infusión continua ×14 d.</p></div>
107
- <div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Ceftriaxona 2 g/24 h IV ×14 d.</p></div>
108
- </div>
109
- <!-- EPI -->
110
- <div id="epi" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
111
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Enfermedad Inflamatoria Pélvica (EPI)</h2>
112
- <div class="treatment-option"><div class="treatment-title">Ambulatorio</div><p>Ceftriaxona 0.5-1 g IM + Doxiciclina 100 mg/12 h VO ×14 d ± Metronidazol 500 mg/12 h ×14 d.</p></div>
113
- <div class="treatment-option"><div class="treatment-title">Hospitalización</div><p>Doxiciclina 100 mg/12 h + Ceftriaxona 2 g + Metronidazol 500 mg/8 h IV ×14 d.</p></div>
114
- <div class="note-box"><div class="note-title">Observaciones</div><ul><li>Hospitalizar en embarazo, absceso o mala respuesta.</li></ul></div>
115
- </div>
116
- <!-- Verrugas genitales -->
117
- <div id="verru" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
118
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Verrugas Genitales</h2>
119
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Podofilotoxina 2 aplicaciones/d ×3 d/semana, Sinacatequinas 3 aplic/d ×16 sem, Imiquimod o 5-FU tópico.</p></div>
120
- <div class="note-box"><div class="note-title">Observaciones</div><ul><li>No requiere estudio etiológico; derivar a dermato (crioterapia).</li></ul></div>
121
- </div>
122
- <!-- Endometritis secundaria -->
123
- <div id="endo_sec" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
124
- <h2 class="text-2xl font-bold text-gray-800 mb-4">Endometritis Secundaria</h2>
125
- <div class="treatment-option"><div class="treatment-title">De elección</div><p>Clindamicina 900 mg IV + Gentamicina 5 mg/kg/24 h IV hasta 48 h afebril.</p></div>
126
- <div class="treatment-option"><div class="treatment-title">Alternativas</div><p>Amoxi/clav 6-8 h o Piperacilina/Tazobactam 4 g/6 h; Ceftriaxona 1 g/24 h + Metronidazol 500 mg/8 h.</p></div>
127
- <div class="note-box"><div class="note-title">Observaciones</div><ul><li>Clinda preferible en lactancia.</li><li>Completar 7 d VO si bacteriemia.</li></ul></div>
128
- </div>
129
- </div>
130
- <script>
131
- const sel=document.getElementById('sel'), res=document.getElementById('result'), store=document.getElementById('store');
132
- sel.addEventListener('change', ()=>{ res.innerHTML=''; const id=sel.value; if(!id) return; const node=store.querySelector('#'+id); if(node) res.appendChild(node.cloneNode(true)); });
133
- </script>
134
- <div class="mt-12 text-center text-sm text-gray-500">
135
- <p>© 2025 Grupo PROA del Hospital de Alcañiz</p>
136
- <p>Elaborado por Dr. Antonio J. Arnal Meinhardt | Médico de Urgencias</p>
137
- </div>
138
- </div>
139
- </body>
140
- </html>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
proa/guias/ginecologia.html ADDED
@@ -0,0 +1,180 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <div id="cerv_sin" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
2
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-question-circle text-purple-500 fa-fw"></i> Cervicitis (sin etiología conocida)</h2>
3
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
4
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
5
+ <p class="text-base text-gray-700">Ceftriaxona 500 mg IM + Azitromicina 1 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p>
6
+ </div>
7
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
8
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
9
+ <p class="text-base text-gray-700">Cefixima 400 mg VO + Azitromicina 2 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p>
10
+ </div>
11
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
12
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
13
+ <p class="text-base text-gray-700">Azitromicina 2 g VO + Doxiciclina 100 mg/12 h VO ×7 d.</p>
14
+ </div>
15
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
16
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
17
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
18
+ <li>Alta sospecha gonococo: Azitromicina preferente.</li>
19
+ </ul>
20
+ </div>
21
+ </div>
22
+
23
+ <div id="cerv_gono" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
24
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-bacteria text-red-500 fa-fw"></i> Cervicitis por N. gonorrhoeae</h2>
25
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
26
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
27
+ <p class="text-base text-gray-700">Ceftriaxona 500 mg IM + Azitromicina 1 g VO.</p>
28
+ </div>
29
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
30
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
31
+ <p class="text-base text-gray-700">Cefixima 400 mg VO + Azitromicina 2 g VO.</p>
32
+ </div>
33
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
34
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
35
+ <p class="text-base text-gray-700">Azitromicina 2 g VO + Gentamicina 240 mg IV o Ciprofloxacino 500 mg VO.</p>
36
+ </div>
37
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
38
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
39
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
40
+ <li>Gonorrea puede diseminarse (conjuntivitis, artropatía).</li>
41
+ <li>Resistencia a quinolonas ≥50%.</li>
42
+ </ul>
43
+ </div>
44
+ </div>
45
+
46
+ <div id="cerv_chlam" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
47
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-viruses text-cyan-500 fa-fw"></i> Cervicitis por C. trachomatis</h2>
48
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
49
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
50
+ <p class="text-base text-gray-700">Azitromicina 1 g VO dosis única o Doxiciclina 100 mg/12 h VO ×7 d.</p>
51
+ </div>
52
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
53
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-biohazard text-red-600 fa-fw"></i> Linfogranuloma venéreo</div>
54
+ <p class="text-base text-gray-700">Doxiciclina 100 mg/12 h VO ×21 d o Azitromicina 1 g VO semanal ×3 semanas.</p>
55
+ </div>
56
+ </div>
57
+
58
+ <div id="vulvo_candi" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
59
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-pastafarianism text-orange-400 fa-fw"></i> Candidiasis Vulvovaginal</h2> <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
60
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
61
+ <p class="text-base text-gray-700">Clotrimazol 500 mg óvulo único o 200 mg/24 h ×3 d; crema 1% ×7-14 d.</p>
62
+ </div>
63
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
64
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
65
+ <p class="text-base text-gray-700">Fluconazol 150 mg VO dosis única.</p> </div>
66
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
67
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-redo text-orange-500 fa-fw"></i> Recurrente / <i class="fas fa-baby text-pink-500 fa-fw"></i> Embarazo</div>
68
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
69
+ <li>Recurrente: Fluconazol 150 mg ×3, luego 150 mg semanal ×6 m.</li>
70
+ <li>Embarazadas: Clotrimazol 100 mg ×7 d.</li>
71
+ </ul>
72
+ </div>
73
+ </div>
74
+
75
+ <div id="vulvo_vagino" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
76
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-bacterium text-teal-500 fa-fw"></i> Vaginosis Bacteriana</h2>
77
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
78
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
79
+ <p class="text-base text-gray-700">Metronidazol 500 mg VO/12 h ×7 d o gel 0.75% 5 g/24 h ×5 d.</p>
80
+ </div>
81
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
82
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
83
+ <p class="text-base text-gray-700">Clindamicina crema 2% 5 g/24 h ×7 d.</p>
84
+ </div>
85
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
86
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
87
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
88
+ <li>No ITS, asociado mayor riesgo de ITS.</li>
89
+ </ul>
90
+ </div>
91
+ </div>
92
+
93
+ <div id="ulc_sif_pri" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
94
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fab fa-stripe-s text-red-600 fa-fw"></i> Sífilis primaria/latente precoz (&lt;1 año)</h2>
95
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
96
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
97
+ <p class="text-base text-gray-700">Penicilina G benzatina 2.4 MUI IM dosis única.</p>
98
+ </div>
99
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
100
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
101
+ <p class="text-base text-gray-700">Azitromicina 2 g VO o Doxiciclina 100 mg/12 h ×14 d.</p>
102
+ </div>
103
+ <div class="note-box bg-pink-50 border-l-4 border-pink-400 p-3 mt-4 rounded-r-lg"> <div class="note-title text-base font-semibold text-pink-800 mb-1.5 flex items-center gap-2"><i class="fas fa-baby text-pink-500 fa-fw"></i> Embarazo</div>
104
+ <p class="text-base text-gray-700">Eritromicina 500 mg/6 h ×14 d + Azitromicina 2 g.</p>
105
+ </div>
106
+ </div>
107
+
108
+ <div id="ulc_sif_lat" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
109
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fab fa-stripe-s text-red-700 fa-fw"></i> Sífilis latente tardía (&gt;1 año)</h2>
110
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
111
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
112
+ <p class="text-base text-gray-700">Penicilina G benzatina 2.4 MUI IM semanales ×3 semanas.</p>
113
+ </div>
114
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
115
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
116
+ <p class="text-base text-gray-700">Doxiciclina 100 mg/12 h VO ×28 d.</p>
117
+ </div>
118
+ </div>
119
+
120
+ <div id="ulc_neuro" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
121
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-brain text-red-800 fa-fw"></i> Neurosífilis</h2>
122
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
123
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
124
+ <p class="text-base text-gray-700">Penicilina G IV 3-4 MUI/4 h o 18-24 MUI infusión continua ×14 d.</p>
125
+ </div>
126
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
127
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
128
+ <p class="text-base text-gray-700">Ceftriaxona 2 g/24 h IV ×14 d.</p>
129
+ </div>
130
+ </div>
131
+
132
+ <div id="epi" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
133
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-female text-pink-600 fa-fw"></i> Enfermedad Inflamatoria Pélvica (EPI)</h2>
134
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
135
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-walking text-green-500 fa-fw"></i> Ambulatorio</div>
136
+ <p class="text-base text-gray-700">Ceftriaxona 0.5-1 g IM + Doxiciclina 100 mg/12 h VO ×14 d ± Metronidazol 500 mg/12 h ×14 d.</p>
137
+ </div>
138
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-red-600"> <div class="treatment-title text-base font-semibold text-red-800 mb-1.5 flex items-center gap-2"><i class="fas fa-hospital text-red-500 fa-fw"></i> Hospitalización</div>
139
+ <p class="text-base text-gray-700">Doxiciclina 100 mg/12 h + Ceftriaxona 2 g + Metronidazol 500 mg/8 h IV ×14 d.</p>
140
+ </div>
141
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
142
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
143
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
144
+ <li>Hospitalizar en embarazo, absceso o mala respuesta.</li>
145
+ </ul>
146
+ </div>
147
+ </div>
148
+
149
+ <div id="verru" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
150
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-disease text-gray-500 fa-fw"></i> Verrugas genitales</h2>
151
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
152
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
153
+ <p class="text-base text-gray-700">Podofilotoxina 2 aplicaciones/d ×3 d/semana, Sinacatequinas 3 aplic/d ×16 sem, Imiquimod o 5-FU tópico.</p>
154
+ </div>
155
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
156
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
157
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
158
+ <li>No requiere estudio etiológico; derivar a dermato (crioterapia).</li>
159
+ </ul>
160
+ </div>
161
+ </div>
162
+
163
+ <div id="endo_sec" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
164
+ <h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-procedures text-pink-600 fa-fw"></i> Endometritis Secundaria</h2>
165
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
166
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
167
+ <p class="text-base text-gray-700">Clindamicina 900 mg IV + Gentamicina 5 mg/kg/24 h IV hasta 48 h afebril.</p>
168
+ </div>
169
+ <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
170
+ <div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativas</div>
171
+ <p class="text-base text-gray-700">Amoxi/clav 6-8 h o Piperacilina/Tazobactam 4 g/6 h; Ceftriaxona 1 g/24 h + Metronidazol 500 mg/8 h.</p>
172
+ </div>
173
+ <div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
174
+ <div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
175
+ <ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
176
+ <li>Clinda preferible en lactancia.</li>
177
+ <li>Completar 7 d VO si bacteriemia.</li>
178
+ </ul>
179
+ </div>
180
+ </div>